Huai Zheng Peng
Vorstandsvorsitzender bei A&B (HK) Co. Ltd.
Ursprung des Netzwerks ersten Grades von Huai Zheng Peng
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Seymour Pierce Ltd.
 Seymour Pierce Ltd. Investment Banks/BrokersFinance Seymour Pierce Ltd. (SP) is an independent Great Britain-based brokerage firm which was established in 1998. SP advises growing privately-owned businesses and publicly quoted UK companies, with a focus on AIM-listed companies. They provide stockbroking, corporate finance, private equity and M&A advisory services and specialize in raising funds for small- and medium-sized UK companies, either facilitating private equity investing or issuing securities. The firm provides sellside analysis to asset managers in Great Britain and internationally, including fund managers, hedge funds and private equity firms. Their research covers a range of sectors including retail, real estate, healthcare, media and entertainment, resources, software, telecommunications, financials, business services and special situations. SP also advises private clients and provides administrative support. They manage equity portfolios on a discretionary basis and provide equity trading accounts, both advisory and execution-only.
30
| Extinct | Investment Banks/Brokers | 30 |
Close Asset Management (UK) Ltd.
 Close Asset Management (UK) Ltd. Investment ManagersFinance Close Asset Management (UK) Ltd., doing business as Close Brothers Asset Management (CBAM), is an investment management firm headquartered in London, UK. The firm is a subsidiary of Close Asset Management Holdings Ltd., itself a subsidiary of Close Brothers Group Plc (LON: CBG). The firm was formerly known as Close Investments Ltd. in 1994 and changed into their current name when Close Brothers Investment, Close Investment, Close Finsbury Asset Management, and Reabourne Technology Investment Management were reorganized into a single legal entity in 2009. CBAM provides a wide variety of financial advisory and investment management services to UK and international intermediaries, private individuals, and institutions such as pension funds. They also manage discretionary portfolios as well as a diverse range of investment products.
18
| Subsidiary | Investment Managers | 18 |
| Public Company | Pharmaceuticals: Major | 13 | |
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA.
10
| Holding Company | Pharmaceuticals: Major | 10 |
| Public Company | Medical Specialties | 9 | |
| Public Company | Pharmaceuticals: Major | 8 | |
| Public Company | Pharmaceuticals: Major | 4 | |
Blueberry Therapeutics Ltd.
 Blueberry Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Blueberry Therapeutics Ltd. engages in the development of innovative medicines. It offers nanomedicine, anti infection and anti microbial, anti inflammatory bowel diseases, acne, dermatitis and wound medicines. The company was founded by John Ridden and Mike Davies and is headquartered in Macclesfield, the United Kingdom.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Northland Bancorp, Inc.
 Northland Bancorp, Inc. Investment ManagersFinance Northland Bancorp, Inc. is a private equity firm located in Calgary, Alberta
2
| Extinct | Investment Managers | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Huai Zheng Peng
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Edison Investment Research Ltd.
 Edison Investment Research Ltd. Investment ManagersFinance Edison Investment Research Ltd. (Edison) is an investment research, investor relations and consulting firm headquartered in London, UK. The firm was founded by Stephen Rogers and Fraser Thorne in 2003. They are a subsidiary of Edison Global Ltd. Edison provides investment research to international investors, advisors and stakeholders. | Investment Managers | Analyst-Equity Analyst-Equity Analyst-Equity Analyst-Equity | |
Panmure Gordon (UK) Ltd.
 Panmure Gordon (UK) Ltd. Investment Banks/BrokersFinance Panmure Gordon (UK) Ltd. (PGL) is the stockbroking subsidiary of Panmure Gordon & Co. Ltd. in Great Britain. Headquartered in London, the firm was founded in 2003 and provides corporate finance advice, distributes and trades securities and produces investment research to UK small and mid-cap corporates and investment companies. PGL has access to capital markets via a range of equity and equity-linked products such as IPOs, accelerated book buildings, placings, rights issues, and bought deals. The firm's institutional equities department provides UK-focused research, sales and trading services to institutional investors in the UK, US and Europe. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity | |
| City University London | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
Cantor Fitzgerald Europe
 Cantor Fitzgerald Europe Investment Banks/BrokersFinance Part of Cantor Fitzgerald LP, Cantor Fitzgerald Europe is a British brokerage company. The company is based in London, UK. The CEOs are Sofocles Sofocleous, Sara Simmons, Juergen Haferkorn. The company was founded in 1945. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity | |
HSBC Bank Plc (Broker)
 HSBC Bank Plc (Broker) Investment Banks/BrokersFinance HSBC Bank Plc (Broker) (HSBC Bank-Broker) is the broker/dealer division of HSBC Bank Plc, which is owned by HSBC Holdings Plc (LON: HSBA; NYSE: HSBC) in Great Britain. Headquartered in London, HSBC Bank-Broker was founded in 1880 and offers bespoke brokerage services across every major asset class for their corporate and institutional clients. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| GEONG INTERNATIONAL LIMITED | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
SpaceCode Holding SA
 SpaceCode Holding SA Investment ManagersFinance SpaceCode Holding SA operates as a holding company whose subsidiaries provide asset tracking system solutions and manufactures diamonds and jewellery. It offers implementation services, prospective customers, and technical support. The company was founded by Pavlo Protopapa and Craig Richard Cook in 2005 and is headquartered in Geneva, Switzerland. | Investment Managers | Chief Executive Officer Chief Executive Officer | |
| University of Leeds | College/University | Doctorate Degree Undergraduate Degree | |
Singer Capital Markets Securities Ltd.
 Singer Capital Markets Securities Ltd. Investment Banks/BrokersFinance Part of N1 Singer Ltd., Singer Capital Markets Securities Ltd. is a brokerage firm. The company is based in London, UK. The British company was founded in 2012 by Timothy Bruce Cockroft, Peter Welch. Timothy Bruce Cockroft has been the CEO since 2012. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Progressive Equity Research Ltd.
 Progressive Equity Research Ltd. Investment ManagersFinance Progressive Equity Research Ltd. provides freely available engaging research and opportunities to hear from a wide range of small and mid-cap UK listed companies. The private company is based in London, UK. The British company covers over 100 stocks across 12 different sectors with 15 analysts having an average experience of over 20 years. The company has an archive of 2000+ research notes and articles and a regular program of investor events, videos, and webinars. The company was founded in 2012 by Gareth Evans, who has been the CEO since 2012. | Investment Managers | Analyst-Equity Analyst-Equity | |
| DERMATA THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Jefferies International Ltd.
 Jefferies International Ltd. Investment Banks/BrokersFinance Jefferies International Ltd. (JIL) is a brokerage firm headquartered in London, UK. The firm was founded in 1986 and is a subsidiary of Jefferies Holdings II Ltd., ultimately held by Jefferies Financial Group, Inc. (NYSE: JEF) in the US. JIL provides broking services to various investors. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| NatWest Markets Plc (Broker) | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| London Business School | College/University | Masters Business Admin Masters Business Admin | |
abrdn Investments Ltd.
 abrdn Investments Ltd. Investment ManagersFinance abrdn Investments Ltd. (aIL) is an asset management firm headquartered in Midlothian, UK. The firm was founded in 1987 and formerly known as Aberdeen Asset Managers Ltd. They are a wholly-owned subsidiary of abrdn Holdings Ltd., wholly-owned by abrdn Plc (LON: ABDN). aIL provides their clients with discretionary and non-discretionary asset management and related services across a broad range of investment strategies and asset classes. They also offer an alternative platform which encompasses multi-manager research, selection and portfolio management for hedge funds strategies. | Investment Managers | Portfolio Manager-Equities Portfolio Manager-Equities | |
Close Asset Management Ltd.
 Close Asset Management Ltd. Investment ManagersFinance Close Asset Management Ltd. (Close AM) is the asset management subsidiary of Close Asset Management Holdings Ltd., itself a subsidiary of Close Brothers Group plc (LSE: CBG, ADR: CBGPY) in Great Britain. The firm was founded in 1982 and does business as Close Brothers Asset Management. Headquartered in London, Close AM provides a bespoke investment management service to private clients, trusts and corporates. | Investment Managers | President Chief Executive Officer | |
Octopus Investments Ltd.
 Octopus Investments Ltd. Investment ManagersFinance Octopus Investments Ltd. is a fund management firm headquartered in London, UK. The firm was founded in 2000 and is owned by Octopus Capital Ltd. Octopus Investments manages investments for retail and institutional investors. They are a socially responsible investor and have established the Octopus Foundation which supports small and medium-sized charities that make a significant social impact. | Investment Managers | Portfolio Manager-Equities Portfolio Manager-Equities | |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| QUESTCOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Operating Officer Sales & Marketing | |
| The University of Manchester | College/University | Undergraduate Degree Graduate Degree | |
| Santa Clara University | College/University | Masters Business Admin Undergraduate Degree | |
| IO BIOTECH, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| The University of Edinburgh | College/University | Undergraduate Degree Undergraduate Degree | |
| University of British Columbia | College/University | Doctorate Degree Undergraduate Degree | |
| University of Bristol | College/University | Doctorate Degree Undergraduate Degree | |
| ZOGENIX, INC. | Pharmaceuticals: Major | Founder Sales & Marketing | |
| The University of Southampton | College/University | Undergraduate Degree Undergraduate Degree | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Wavebreak Therapeutics Ltd.
 Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member | |
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member | |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member | |
Stifel Nicolaus Europe Ltd.
 Stifel Nicolaus Europe Ltd. Investment Banks/BrokersFinance Stifel Nicolaus Europe Ltd. (SNEL) is a brokerage firm headquartered in London, UK. The firm was founded in 1999 and do-business-as Keefe, Bruyette & Woods Ltd. (KBW). They are a subsidiary of Stifel Europe Holdings Ltd., ultimately owned by Stifel Financial Corp. (NYSE: SF) in the US. SNEL provides Pan-European equity research and sales and trading products for their institutional clients. | Investment Banks/Brokers | Analyst-Equity | |
Brandon Point Industries Ltd.
 Brandon Point Industries Ltd. Medical/Nursing ServicesHealth Services Brandon Point Industries Ltd. operates as a life sciences company. It focuses on healthcare. The company was founded in 2014 by George Kelly Martin and John Oliver Thomas Given and is headquartered in Dublin, Ireland. | Medical/Nursing Services | Director/Board Member | |
| University of London | College/University | Doctorate Degree | |
| EVOTEC SE | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistik
International
| Vereinigtes Königreich | 31 |
| Vereinigte Staaten | 11 |
| Kanada | 4 |
| Schweiz | 3 |
| China | 2 |
Sektoral
| Finance | 23 |
| Health Technology | 14 |
| Consumer Services | 11 |
| Commercial Services | 4 |
| Non-Energy Minerals | 2 |
Operativ
| Director/Board Member | 223 |
| Corporate Officer/Principal | 124 |
| Analyst-Equity | 83 |
| Chairman | 53 |
| Director of Finance/CFO | 51 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| David Hale | 54 |
| Alan Roy Matthews | 22 |
| Andrew Clark | 20 |
| Savio Chiu | 19 |
| Nick Rodgers | 18 |
| David Smith | 17 |
| Richard William Killingbeck | 16 |
| Stephen Stamp | 15 |
| Justin Jordan | 14 |
| Adrian Howd | 14 |
| Frédéric Duchesne | 13 |
| Blane Walter | 12 |
| John Johnston | 12 |
| Brian Bapty | 12 |
| Debra Stephanie Barker | 11 |
- Börse
- Insiders
- Huai Zheng Peng
- Unternehmensverbindungen
